Commentary: Let us ponder - Choosing between topical Nepafenac and topical steroids after cataract surgery
- PMID: 35225520
- PMCID: PMC9114600
- DOI: 10.4103/ijo.IJO_2782_21
Commentary: Let us ponder - Choosing between topical Nepafenac and topical steroids after cataract surgery
Conflict of interest statement
None
Comment on
-
Comparison of once daily dose of 0.3% nepafenac alone and three times dose of 0.1% nepafenac alone in pain and inflammation control after phacoemulsification.Indian J Ophthalmol. 2022 Mar;70(3):807-812. doi: 10.4103/ijo.IJO_2401_21. Indian J Ophthalmol. 2022. PMID: 35225519 Free PMC article. Clinical Trial.
References
-
- Jampol LM, Jain S, Weinreb RN. Non steroidal anti-inflammatory drugs and cataract surgery. Arch Ophthalmol. 1994;112:891–4. - PubMed
-
- Gamache DA, Graff G, Brady MT, Spellman JM, Yanni JM. Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular infl ammation:I. Assessment of anti-inflammatory efficacy. Inflammation. 2000;24:357–70. - PubMed
-
- Chu CJ, Johnston RL, Buscombe C, Sallam AB, Mohamed Q, Yang YC. United Kingdom Pseudophakic Macular Edema study group risk factors and incidence of macular edema after cataract surgery:A database study of 81984 eyes. Ophthalmology. 2016;123:316–23. - PubMed
-
- Boscia F, Giancipoli E, D'Amico Ricci G, Pinna A. Management of macular oedema in diabetic patients undergoing cataract surgery. Curr Opin Ophthalmol. 2017;28:23–8. - PubMed
-
- Gaynes BI, Fiscella R. Topical nonsteroidal anti- inflammatory drugs for ophthalmic use. Drug Safety. 2002;25:2334–50. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical